Prof Dr Markus Schott > Bär & Karrer Ltd. > Zurich, Switzerland > Lawyer Profile

Fielding a comprehensive insurance offering, Bär & Karrer Ltd. advises a consortium of clients on license applications, regulatory compliance, transactions and disputes. Peter Hsu spearheads the practice with his wide-ranging expertise advising Swiss and foreign insurers, insurance intermediaries and fintech businesses on a diverse spread of matters. Financial services expert Eric Stupp’s strengths lie in regulatory matters, enforcement proceedings and M&A. Daniel Flühmann is well versed in the remits of banking, insurance and financial market laws, while Markus Schott is well equipped to manage a variety of regulatory and administrative law matters. Tiffany Ender is also recommended.

Bär & Karrer Ltd. advises domestic and international clients on the full spectrum of public and governmental service-related matters, with expertise in the healthcare, financial, infrastructure, and gambling industries, among others. The ‘highly qualified’ team has a particular focus on export controls relating to war materials and dual use goods. Practice head Markus Schott has extensive experience in administrative and regulatory matters, including governmental supervision, public procurement, and administrative sanctions. Vera Naegeli specialises in ESG matters, white collar crime, and compliance issues. Public institution financing expert Frédéric Bétrisey also supports the team. Raphael Wyss advises clients in the life sciences, telecommunications, and energy sectors.

The market-leading team at Bär & Karrer Ltd. advises its lucrative client base of on the full gamut of matters, including the marketing and advertising of drugs and pricing proceedings. Jointly heading the practice in Zurich, Markus Schott primarily focuses on administrative proceedings, including government supervision and public procurement mandates; Markus Wang  leads on the intellectual property (IP) side, acting for pharma and biotech clients in Swissmedic proceedings; and Philippe Seiler maintains a private equity and M&A focused practice, handling a variety of transactions and regulatory matters involving medical device and drug distribution. Basel based practice co-head Claudia Götz Staehelin is an expert in investigations, disputes, and regulatory issues, representing numerous global pharma giants, while co-head Oliver Brupbacher is noted for his ‘exceptional‘ sector knowledge, and his expertise in crisis management issues and information governance. Jannick Koller left the practice in December 2022.